Trial intelligence / Profile preview

Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass

NCT02271997Phase 4Completed

Sponsor
Rijnstate
Start
Dec 2014
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Rijnstate. Started Dec 2014; status: completed.

02

Drugs

ferric carboxymaltose
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT02271997.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02271997.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call